Ayşegül AKYÜZ
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ayşegül AKYÜZ has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Emrah Aytaç
Interventional Neurology, Department of Neurology, Faculty of Medicine, Fırat University Firat University Elazığ Turkey
1 shared publication - Hanzade Aybuke Unal
Department of Pain Medicine, Faculty of Medicine, Ankara University, 06230 Ankara, Türkiye
1 shared publication - Hasan Göğebakan
Division of Rheumatology, Department of Internal Medicine, Bursa City Hospital, University of Health Sciences, Bursa 16110, Turkey
1 shared publication - Ismail Volkan Sahiner
Kütahya Health Sciences University
1 shared publication - Mehmet Öztürk
ANKARA EĞİTİM VE ARAŞTIRMA HASTANESİ, RUH SAĞLIĞI VE HASTALIKLARI
1 shared publication - Mevlüt Gökhan Sucu
Department of Pain Medicine , Mersin City Training and Research Hospital , University of Health Sciences , Mersin , Türkiye , akdeniz.edu.tr
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Pain Research and Management
- Vol. 2026 (1) , 7897619
Short‐ and Midterm Analgesic Outcomes of Ketamine Versus Lidocaine Infusion in Chronic Peripheral Neuropathic Pain: A Retrospective Study
Background: Intravenous ketamine and lidocaine infusions are increasingly used for chronic peripheral neuropathic pain, particularly in refractory cases. However, comparative data on their short‐ and midterm analgesic outcomes in routine clinical practice are limited. Methods: This retrospective study included patients with chronic peripheral neuropathic pain who received intravenous ketamine or lidocaine infusion between January and May 2021. Ketamine was administered at 1 mg/kg/h and lidocaine at 3 mg/kg/h for five consecutive days. Pain intensity and neuropathic pain features were assessed using the Numeric Rating Scale (NRS) and the Douleur Neuropathique 4 (DN4) questionnaire at baseline and at 2 weeks, 2 months, and 6 months after treatment. Clinically meaningful pain relief was defined as a ≥ 50% reduction in pain scores. Results: A total of 102 patients were analyzed (ketamine group, n = 44; lidocaine group, n = 58). Both groups showed significant reductions in NRS and DN4 scores at all follow‐up points compared with baseline ( p < 0.01). Clinically meaningful pain relief was more frequent in the ketamine group at 2 weeks ( p < 0.01), whereas no significant differences were observed at 2 and 6 months ( p > 0.05). Adverse effects occurred more often with ketamine, while lidocaine was associated with fewer side effects ( p < 0.05). Conclusion: Ketamine provided a greater early analgesic response at 2 weeks, whereas both treatments demonstrated comparable midterm efficacy at 2 and 6 months. Trial Registration: ClinicalTrials.gov identifier: NCT06297915
- 1 January 2026
- Published by Wiley in Pain Research and Management
- Vol. 2026 (1) , 7897619
Open AccessShort‐ and Midterm Analgesic Outcomes of Ketamine Versus Lidocaine Infusion in Chronic Peripheral Neuropathic Pain: A Retrospective Study
Background: Intravenous ketamine and lidocaine infusions are increasingly used for chronic peripheral neuropathic pain, particularly in refractory cases. However, comparative data on their short‐ and midterm analgesic outcomes in routine clinical practice are limited. Methods: This retrospective study included patients with chronic peripheral neuropathic pain who received intravenous ketamine or lidocaine infusion between January and May 2021. Ketamine was administered at 1 mg/kg/h and lidocaine at 3 mg/kg/h for five consecutive days. Pain intensity and neuropathic pain features were assessed using the Numeric Rating Scale (NRS) and the Douleur Neuropathique 4 (DN4) questionnaire at baseline and at 2 weeks, 2 months, and 6 months after treatment. Clinically meaningful pain relief was defined as a ≥ 50% reduction in pain scores. Results: A total of 102 patients were analyzed (ketamine group, n = 44; lidocaine group, n = 58). Both groups showed significant reductions in NRS and DN4 scores at all follow‐up points compared with baseline ( p < 0.01). Clinically meaningful pain relief was more frequent in the ketamine group at 2 weeks ( p < 0.01), whereas no significant differences were observed at 2 and 6 months ( p > 0.05). Adverse effects occurred more often with ketamine, while lidocaine was associated with fewer side effects ( p < 0.05). Conclusion: Ketamine provided a greater early analgesic response at 2 weeks, whereas both treatments demonstrated comparable midterm efficacy at 2 and 6 months. Trial Registration: ClinicalTrials.gov identifier: NCT06297915
- Open Access
- 29 January 2023
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 5 (1) , 41-47
The relationship between the frequency and severity of restless legs syndrome and anaemia in patients with ankylosing spondylitis
Background Background The study aims to determine the frequency of restless legs syndrome (RLS) in patients with ankylosing spondylitis (AS) and the relationship between the International Restless Legs Syndrome Study Group Rating Scale (IRLSSG-RS) score and anemia. Material and Methods It was a case-control study that included 106 patients with AS and 106 age- and sex-matched healthy controls in the rheumatology clinic of a training and research hospital. The patients were divided into two groups according to their hemoglobin levels. A hemoglobin level lower than 12 g/dL in women and less than 13 g/dL in men was the criterion for anemia. Results Although the frequency of RLS was higher in AS patients than in control groups, there was no significant difference in the IRLSSG-RS score between AS patients and control groups. 23 (57.5%) of the AS patients with anemia had RLS, and the IRLSSG-RS score was 21.3±5.7. Of the AS patients without anemia, 11 (16.7%) had RLS, and the IRLSSG-RS score was 15±6. Statistically significant differences between AS patients with and without anemia regarding RLS frequency and IRLSSG-RS score were found. The IRLSSG-RS scores of AS patients were negatively correlated with serum iron and hemoglobin level. Conclusions Patients with AS had a higher RLS frequency than the control group; AS patients with anemia had a higher RLS and IRLSSG-RS score than AS patients without anemia. Also, a negative and significant correlation was found between the IRLSS-RS score and serum iron and hemoglobin levels in AS patients.
- 29 January 2023
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 5 (1) , 41-47
Open AccessThe relationship between the frequency and severity of restless legs syndrome and anaemia in patients with ankylosing spondylitis
Background Background The study aims to determine the frequency of restless legs syndrome (RLS) in patients with ankylosing spondylitis (AS) and the relationship between the International Restless Legs Syndrome Study Group Rating Scale (IRLSSG-RS) score and anemia. Material and Methods It was a case-control study that included 106 patients with AS and 106 age- and sex-matched healthy controls in the rheumatology clinic of a training and research hospital. The patients were divided into two groups according to their hemoglobin levels. A hemoglobin level lower than 12 g/dL in women and less than 13 g/dL in men was the criterion for anemia. Results Although the frequency of RLS was higher in AS patients than in control groups, there was no significant difference in the IRLSSG-RS score between AS patients and control groups. 23 (57.5%) of the AS patients with anemia had RLS, and the IRLSSG-RS score was 21.3±5.7. Of the AS patients without anemia, 11 (16.7%) had RLS, and the IRLSSG-RS score was 15±6. Statistically significant differences between AS patients with and without anemia regarding RLS frequency and IRLSSG-RS score were found. The IRLSSG-RS scores of AS patients were negatively correlated with serum iron and hemoglobin level. Conclusions Patients with AS had a higher RLS frequency than the control group; AS patients with anemia had a higher RLS and IRLSSG-RS score than AS patients without anemia. Also, a negative and significant correlation was found between the IRLSS-RS score and serum iron and hemoglobin levels in AS patients.
- 31 August 2021
- Published by Medical Journal of Ankara Training and Research Hospital in Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi
- Vol. 54 (2) , 263-270
AKUT İSKEMİK İNME VE GEÇİCİ İSKEMİK ATAK GEÇİREN HASTALARDA MİZAÇ KİŞİLİK ÖZELLİKLERİ VE YAŞAM OLAYLARININ İNCELENMESİ
Akut iskemik inme ve geçici iskemik atak geçiren hastalarda mizaç kişilik özellikleri ve yaşam olaylarının etkisi ÖZET AMAÇ: Akut iskemik inme ve geçici iskemik atak vasküler hasara bağlı olarak serebral kan akımının bozulması nedeniyle gelişir. İnme gelişiminde çeşitli genetik ve çevresel nedenler sorumlu olmakla birlikte çalışmalarda psikolojik faktörlerin de rol alabileceği saptanmıştır. Bu çalışmada kişilik özellikleri, mizaç ve geçirilmiş yaşam olaylarının inme ile ilişkili olup olmadığını saptamak amaçlanmıştır. GEREÇ VE YÖNTEM: Çalışmaya NIH İnme Ölçeği puanı 10’nun altında olan, afazik olmayan, demans ve başka bilişsel bozukluğu olmayan 48 akut iskemik inme veya geçici iskemik atak geçiren hasta ile yaş ve cinsiyet uyumlu 47 gönüllü kontrol grubu dahil edilmiştir. Hasta ve kontrol grubuna sosyodemografik veri formu, Memphis, Pisa, Paris and San Diego Mizaç Değerlendirme Anketi, Mizaç ve Karakter Envanteri ve Yaşam Olayları Listesi uygulanmıştır. BULGULAR: İnme hastaları ile kontrol grubunda yer alan sağlıklı bireyler arasında Memphis, Pisa, Paris and San Diego Mizaç Değerlendirme Anketinin depresif mizaç, irritabl mizaç ve anksiyöz mizaç alt ölçek puanları açısından istatistiksel olarak anlamlı fark saptanmıştır. Çalışma grupları arasında Yaşam Olayları Listesi ölçeğinin distres ve uyum alt ölçek puanları açısından istatistiksel olarak anlamlı bir fark saptanmamıştır. Mizaç Karakter Envanteri ise her iki grup arasında yenilik arayışı, zarardan kaçınma, sebat etme, kendi kendini yönetme ve iş birliği puanları açısından anlamlı farklılıklar saptanmıştır. SONUÇ: İnme hastalarının depresyona eğilimli mizaç ve karakter özelliklerine sahip olduğunu tespit edilmiştir. Bu çalışma, ülkemizde inme geçiren hastaların mizaç ve karakter özellikleri ve yaşam olayları karşında verdikleri distres ve uyumu değerlendiren ilk çalışmadır. Anahtar sözcükler: İskemik inme, kişilik, yaşam olayları
- 31 August 2021
- Published by Medical Journal of Ankara Training and Research Hospital in Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi
- Vol. 54 (2) , 263-270
AKUT İSKEMİK İNME VE GEÇİCİ İSKEMİK ATAK GEÇİREN HASTALARDA MİZAÇ KİŞİLİK ÖZELLİKLERİ VE YAŞAM OLAYLARININ İNCELENMESİ
Akut iskemik inme ve geçici iskemik atak geçiren hastalarda mizaç kişilik özellikleri ve yaşam olaylarının etkisi ÖZET AMAÇ: Akut iskemik inme ve geçici iskemik atak vasküler hasara bağlı olarak serebral kan akımının bozulması nedeniyle gelişir. İnme gelişiminde çeşitli genetik ve çevresel nedenler sorumlu olmakla birlikte çalışmalarda psikolojik faktörlerin de rol alabileceği saptanmıştır. Bu çalışmada kişilik özellikleri, mizaç ve geçirilmiş yaşam olaylarının inme ile ilişkili olup olmadığını saptamak amaçlanmıştır. GEREÇ VE YÖNTEM: Çalışmaya NIH İnme Ölçeği puanı 10’nun altında olan, afazik olmayan, demans ve başka bilişsel bozukluğu olmayan 48 akut iskemik inme veya geçici iskemik atak geçiren hasta ile yaş ve cinsiyet uyumlu 47 gönüllü kontrol grubu dahil edilmiştir. Hasta ve kontrol grubuna sosyodemografik veri formu, Memphis, Pisa, Paris and San Diego Mizaç Değerlendirme Anketi, Mizaç ve Karakter Envanteri ve Yaşam Olayları Listesi uygulanmıştır. BULGULAR: İnme hastaları ile kontrol grubunda yer alan sağlıklı bireyler arasında Memphis, Pisa, Paris and San Diego Mizaç Değerlendirme Anketinin depresif mizaç, irritabl mizaç ve anksiyöz mizaç alt ölçek puanları açısından istatistiksel olarak anlamlı fark saptanmıştır. Çalışma grupları arasında Yaşam Olayları Listesi ölçeğinin distres ve uyum alt ölçek puanları açısından istatistiksel olarak anlamlı bir fark saptanmamıştır. Mizaç Karakter Envanteri ise her iki grup arasında yenilik arayışı, zarardan kaçınma, sebat etme, kendi kendini yönetme ve iş birliği puanları açısından anlamlı farklılıklar saptanmıştır. SONUÇ: İnme hastalarının depresyona eğilimli mizaç ve karakter özelliklerine sahip olduğunu tespit edilmiştir. Bu çalışma, ülkemizde inme geçiren hastaların mizaç ve karakter özellikleri ve yaşam olayları karşında verdikleri distres ve uyumu değerlendiren ilk çalışmadır. Anahtar sözcükler: İskemik inme, kişilik, yaşam olayları